This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,453 Years Active: 2004
Title: Innovations of David Mark Meredith in Gene Therapy
Introduction
David Mark Meredith is an accomplished inventor based in Leeds, GB. He has made significant contributions to the field of gene therapy, particularly through his innovative work with equine herpes virus.
Latest Patents
Meredith holds a patent for EHV-1 vectors. This invention focuses on the manipulation of equine herpes virus for use in gene therapy. The modifications allow the virus to carry heterologous material and, preferably, be replication deficient. This ensures that the virus cannot replicate in the target tissue, enhancing the safety and efficacy of gene therapy applications.
Career Highlights
Throughout his career, David Mark Meredith has demonstrated a commitment to advancing medical science. His work has implications not only for veterinary medicine but also for potential applications in human gene therapy.
Collaborations
Meredith has collaborated with Alexander Fred Markham, further enriching his research and development efforts in the field.
Conclusion
David Mark Meredith's innovative work with EHV-1 vectors represents a significant advancement in gene therapy, showcasing his dedication to improving therapeutic techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile